J Pediatr Genet 2022; 11(01): 047-050
DOI: 10.1055/s-0040-1714699
Case Report

Large Mesenteric Gaucheroma Responds to Substrate Reduction Therapy: A New Management of Gaucheromas

1   Division of Genetics, Department of Pediatrics, Los Angeles County + USC Medical Center, University of Southern California, Los Angeles, California, United States
,
Kathryn Moseley
1   Division of Genetics, Department of Pediatrics, Los Angeles County + USC Medical Center, University of Southern California, Los Angeles, California, United States
,
Neha Mahajan
2   Department of Pediatrics, Los Angeles County + USC Medical Center, University of Southern California, Los Angeles, California, United States
,
Mikako Warren
3   Department of Pathology, Children's Hospital Los Angeles, University of Southern California, Los Angeles, California, United States
,
Linda Vachon
4   Department of Radiology, Los Angeles County + USC Medical Center, University of Southern California, Los Angeles, California, United States
› Author Affiliations
Funding None.

Abstract

Gaucheromas, which are pseudotumors consisting of a cluster of Gaucher cells, are rare complications in Gaucher's disease (GD) and reported in patients treated with enzyme replacement therapy (ERT). Gaucheromas commonly develop in the lymph nodes in the mesenteric and mediastinal regions and can cause serious complications including protein-losing enteropathy. A large mesenteric Gaucheroma showed a significant reduction in size after initiation of substrate reduction therapy (SRT) with eliglustat in an adult patient with GD type 3. Combination therapy with ERT and SRT should be considered to prevent Gaucheromas in patients with GD.

Note

Written informed consent was obtained from the patient for publication of this case report.


Ethical Approval

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Declaration of Helsinki 1975. Informed consent was obtained from the patients (and/or the parents) reported in this case report and the patient agreed with the content and with submitting this case report for consideration for publication in this journal.


The report of single case without identifiable information in the case report not requiring Institutional Review Board approval or ethics approval from the University of Southern California.




Publication History

Received: 01 May 2020

Accepted: 12 June 2020

Article published online:
29 July 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany